Live at HLTH: Solving for the Disparity in Cancer Outcomes—featuring Feyi Olopade Ayodele
For most cancers, Black Americans have the highest death rate and shortest survival of any patient population.
And access to genetic testing is key to eliminating this disparity.
Feyi Olopade Ayodele is Cofounder and CEO of CancerIQ, a company on a bold mission to end cancer as we know it by giving providers and health systems access to the latest innovations in early cancer detection and prevention.
Under Feyi’s leadership, CancerIQ has grown its provider network to over 200 locations across the US and established a robust ecosystem of leading diagnostic and genomic testing vendors.
On this…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.